Th e aim of the study was to detect HIV RNA in seropositive patients using RT-PCR method and thus, to establish PCR methodology in the routine laboratory works. Th e total of  examined persons were divided in two groups: )  persons seropositive for HIV; and )  healthy persons -randomly selected blood donors that made the case control group. Th e subjects age was between  and  years (average ,). ELFA test for combined detection of HIV p antigen and anti HIV-+ IgG and ELISA test for detection of antibodies against HIV- and HIV-, were performed for each examined person. RNA from the whole blood was extracted using a commercial kit based on salt precipitation. Detection of HIV RNA was performed using RT-PCR kit. Following nested PCR, the product was separated by electrophoresis in ,  agarose gel. Th e result was scored positive if the band of bp was visible regardless of intensity. Measures of precaution were taken during all the steps of the work and HIV infected materials were disposed of accordingly. In the group of blood donors ELFA, ELISA and RT-PCR were negative. Assuming that prevalence of HIV infection is zero, the clinical specifi city of RT-PCR is  . Th e analytical specifi city of RT-PCR method was tested against Hepatitis C and B, Human Papiloma Virus, Cytomegalovirus, Herpes Simplex Virus, Rubella Virus, Mycobacterium tuberculosis, Chlamydia trachomatis. None of these templates yielded amplicon. In the group of  seropositive persons,  samples were analyzed. HIV RNA was detected in  samples. ELISA and ELFA test were positive in all samples. Diff erent aliquots of the samples were tested independently and showed the same results. After diff erent periods of storing the RNA samples at -ºC, RT-PCR reaction was identical to the one performed initially. Th e obtained amplicons were maintained frozen at -ºC for a week and the subsequently performed electrophoresis was identical to the previous one. Th e reaction is fast, simple for manipulation; with low detection level of  IU/ml. RT-PCR needs a small amount of RNA, as well as a small volume of sample. HIV RNA was detected in diff erent periods of time with diff erent clinical presentations in patients, with or without antiretroviral therapy. RT-PCR method gives the opportunity for reliable determination of HIV- RNA with border of detection of  IU/ml. Th e test is reproducible and has high analytical and clinical specifi city.
Introduction
Th ree crucial questions regarding HIV diagnostics have been addressed in medicine worldwide over the last years: whether the subject was infected, how active HIV replication was, and how sensitive to retroviral therapy the virus was? Detection of virus genome made by in situ hybridization or Polymerase Chain Reaction (PCR) is an attempt to provide answers to all of the three questions. Two methods for detection of HIV RNA are available: Target amplifi cation with modalities of Reverse transcriptase (RT) PCR and Nucleic acid sequencebased amplifi cation assay (NASBA), and Signal amplification, as branch DNA test (-) . Clinical relevance of those assays dependens on their reproducibility and amplifi cation dynamics for diff erent genotypes. Some studies addressed comparisons of the results obtained from diff erent assay systems (-) . Th e aims of the study are to introduce PCR methodology in HIV diagnostics in our country and to detect HIV RNA with nested RT-PCR in seropositive subjects in order to evaluate analytical specifi city and reproducibility of this method.
Patients and Methods
Th e case control study involved  subjects, divided in two groups: a) HIV seropositive subjects ( patients) , and b) Sedentary healthy subjects ( blood donors).
Seropositive patients, according to the HIV transmission, were divided in three groups: heterosexuals ( patients); intravenous drug users ( patient) , and homosexuals ( patients).  of seropositive patients were men and  women, with mean age of , years (range from  to  years old). Th e mean age of control group was , years (range from  to  years old). In all patients, the following tests were done: ELFA test (BioMerieux -HIV duo) for combined detection of HIV- p and anti-HIV- and anti-HIV- IgG and ELI-SA (NeoDin ™) for detection of HIV- and HIV- antibodies. Examined material was whole blood, taken in  ml Vacutainer tube with EDTA as anticoagulant. RNA was isolated from the plasma sample using Purescript RNA Isolation kit (Gentra systems). Th e procedure is based on salt precipitation with highly eff ective inhibitors of RNA activity which allows isolation of RNA from cells and body fl uids. Th e fi rst step is cell lysis using anionic detergent. DNA and proteins are separated with salt precipitation. RNA is isolated with alcohol precipitation and dissolved in RNAse free water. After the isolation RNA yield was verifi ed in , agarose gel ( Figure ) . HIV detection was performed with qualitative RT-PCR in one step with NeoDin kit. Th e kit consists of: ) RT-PCR mix of: four nucleotides (dNTPs) -dATPdeoxyadenine triphosphate; dGTP-deoxyguanine triphosphate; dTTP-deoxythymine triphosphate; dCTP-deoxycytosine triphosphate;  X reaction buff er (Tris -HCl, KCl and MgCl); dithiotreitol (DTT); ' and ' primers designed for reverse transcriptase gene detection and deionized water. Th e same primers are used in reverse transcription and fi rst amplifi cation of cDNA. ) RT-Enzyme  -with a function of reverse transcriptase ) RT-Enzyme  -with a polymerase activity, ) PCR mix for nested PCR of: four dNTPs,  X reaction buff er, primers for nested amplifi cation, cresol red, glycerol and deionizated water; ) PCR Enzyme -with polymerase activity; ) Positive control; ) Mineral oil. Deoxyuracil triphosphate (dUTP) and uracil-N-glycosylase are added to the reaction (-) .
Th e method is based on HIV RNA transcription into complementary DNA copy (cDNA). Amplifi cation was conducted under following conditions: for reverse transcription  min at °C,  min at °C,  min. at °C-one cycle; and for amplifi cation  sec at °C,  sec at °C,  sec at °C - cycles and one cycle at °C for  min. Th e conditions of the nested PCR were:  min at °C one cycle;  sec at °C,  sec at °C,  sec at °C for  cycles; and one cycle at °C for  min (-). PTC-™ Th ermal Cycler (MJ Research, inc.) was used. PCR products were separated using , agarose gel electrophoresis. Ethidium bromide was added () . UV transiluminator was used for visualization of the bands. The result was scored positive if band of  bp was present regardless of intensity. Th e procedures were performed in Virology Laboratory in Republic Institute for Health Protection, Skopje, Macedonia, with biological protection class II. One-way process (pre-amplifi cation to post-amplifi cation) was used.
Results
HIV RNA was not detected in any of the case control patients: examples were not reactive to RT PCR kit. Supposing that prevalence of HIV- infection in seronegative blood donors is zero, we obtained test specifi city . To estimate analytical specificity of the test, we attempted amplifi cation of nucleic acids pf Hepatitis C were frozen at -°C, and reanalyzed by electrophoresis. Th e results did not diff er from the fi rst electrophoresis. Th e results of electrophoresis are shown in Figure  .
Discussion
We tested a commercial test, applicable for extraction, reverse transcription and amplifi cation of HIV RNA. In routine work time consumed is a very important thing. Period of  hours that elapsed during our analysis (from samples received to the fi nal results) is relatively short. We isolated total RNA from whole blood, with ready for use kit based on salt precipitation according Nelson and Kim recomendations () . Low amount of required material is of utmost importance. Our method required  μl of whole blood to yield  μl of isolated RNA. Cunningham et al. compared RT PCR and DNA PCR tests for the detection of HIV and concluded that the former is more sensitive ( to ). Sensitivity of qualitative RNA test is more pronounced than of the quantitative one () . The test that we used did have performance of RNA detection of  IU/ml as the lowest limit. Using the primers located for pol gene sequence variability has been avoided and bigger sensitivity got () . We used the method that Roche Molecular Biochemicals did for determination of clinical and analytical specifi city of Amplicor HIV- Monitor test v.., which is the oldest PCR method certifi ed by Food and Drug Administration. Clinical specificity of the test is determined when in healthy blood donors: anti HIV antibodies and p antigen, as weel as HIV RNA were not detected. Th us, we got clinical specifi city of . Analytical specify is detected when nucleic acids are used to test their reactivity to HIV- primers. None of those showed any reactivity, which indicates high analytical specifi city of the test. In order to test the reproducibility different aliquots of the same sample were tested independently. All of these concurred with the earlier result and confirmed the test as reproducible. The suspended RNA was preserved at temperature °C max for one week. When the analysis is postponed for a long time freezing at -°C is recommended () . In prolonged storage RNA degradation is expectable. We maintained RNA frozen at - for one year, but we did not find any RNA degradation. Sometimes it is necessary to postpone electrophoresis and store amplicons at -°C. After amplicons were stored at-°C for one week and rerun in aga- 
Conclusion
According to our data we can conclude that RT-PCR method enables reliable determination of HIV- RNA with limit of detection at  IU/ml. Th e test is reproducible and has high analytical and clinical specifi city. Qualitative RT-PCR method for the detection of HIV RNA is recommended for use in routine laboratory work for documentation of HIV infection, as well as for the clinical management of HIV infected patients and monitoring of antiretroviral therapy effi cacy.
